Concepedia

Author

Kazuomi Ueshima

Kindai UniversityORCID

Also Known As

K Ueshima, K. Ueshima, K., Ueshima, Kanako Ueshima, Kazuomi Ueshima, Susumu Shiomi, Ueshima, K.

395

Publications

9K

Citations

46

H-Index

81

Concepts

All Affiliations

Kindai UniversityNational Cancer Center Hospital EastKyoto UniversityMusashino Red Cross HospitalKurume University
KU

About

Kazuomi Ueshima is an author at Kindai University specializing in medicine, oncology, and hepatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

28

1.6K

2

Health Sciences

18

21

1.5K

3

Engineering

2

2

134

4

Biostatistics

1

1

23

5

Cell Biology

1

1

60

Kazuomi Ueshima

×

120

Publications

6.5K

Citations

43

H-Index

YearCitations

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda,

Gut

2019

686

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial

Masatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka,

˜The œLancet. Gastroenterology & hepatology

2018

303

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan,

Cancers

2019

291

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

Kiyoshi Hasegawa, Nobuyuki Takemura, Tatsuya Yamashita,

Hepatology Research

2023

235

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami,

Liver Cancer

2015

203

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Tokuzo Arao, Kazuomi Ueshima, Tomoyuki Nagai,

Hepatology

2012

152

Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid

Kinuyo Hatanaka, Masatoshi Kudo, Yasunori Minami,

Intervirology

2008

150

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study

Kazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara,

Cancers

2019

140

Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima,

Liver Cancer

2023

127

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima,

ESMO Open

2022

124

Page 1